Last Updated: May 10, 2026

Suppliers and packagers for LIGNOSPAN FORTE


✉ Email this page to a colleague

« Back to Dashboard


LIGNOSPAN FORTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Septodont, Inc. 0362-0262-05 50 CARTRIDGE in 1 CARTON (0362-0262-05) / 1.7 mL in 1 CARTRIDGE 2018-08-10
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Septodont, Inc. 0362-1096-70 5 BLISTER PACK in 1 CARTON (0362-1096-70) / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGE 2017-12-01
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Henry Schein Inc. 0404-6500-15 50 CARTRIDGE in 1 CARTON (0404-6500-15) / 1.7 mL in 1 CARTRIDGE 2011-11-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies LIGNOSPAN FORTE?

Last updated: April 25, 2026

Who manufactures and supplies LIGNOSPAN FORTE?

No reliable, citable manufacturing or supply-party data is available from the provided input. As a result, a complete and accurate supplier mapping (manufacturer, brand owner, marketing authorization holder, and distribution channels) cannot be produced.

What supplier-level entities exist in the supply chain for this product?

A defensible supplier set for a pharmaceutical brand normally includes:

  • Marketing authorization holder (MAH) (or equivalent regulatory owner)
  • Manufacturer of finished dosage form (FDF) (site-level)
  • Manufacturer of active ingredient (API) (site-level, if disclosed)
  • Primary distributor/wholesaler (where disclosed by country-specific listings)
  • Importer of record (where applicable)

What proof is available from the provided information?

None. The prompt contains only the product name “LIGNOSPAN FORTE” and does not include:

  • country of sale (critical for regulator-driven records),
  • dosage form and strength,
  • authorization number or registration identifiers,
  • label/pack details,
  • or any source link to regulatory databases, listings, or catalogs.

What supplier list can be delivered from the provided input?

None. Delivering a supplier list without sourced, identifier-based confirmation would not meet the requirements for accuracy in a patent- and R&D-relevant supply assessment.

Key Takeaways

  • No supplier identification can be produced from the provided input.
  • No manufacturer, MAH, API, or distribution-party names can be listed without citable regulatory or label evidence tied to “LIGNOSPAN FORTE.”
  • A complete supplier map requires product-specific regulatory identifiers (not present in the input).

FAQs

  1. Can I get the manufacturer for “LIGNOSPAN FORTE” from the product name alone?
    Not with accuracy suitable for high-stakes R&D or investment decisions.

  2. Does “supplier” mean MAH or the factory making the tablets/capsules?
    Supplier mapping typically includes both MAH and the FDF manufacturing site when disclosed.

  3. Do supplier identities change by country?
    Yes, brand ownership and distribution often differ by market.

  4. Can distributors be inferred from retailer listings?
    Retail listings are not a substitute for regulatory/label-linked supplier identification.

  5. Is there an authoritative place to verify LIGNOSPAN FORTE suppliers?
    Yes, but the needed identifiers or source documents are not included in the provided input.

[1]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.